Featured Image

Why is it important?

important for decision making in dose reduction of S-1 in case of renal impairment

Read the Original

This page is a summary of: Pharmacokinetic study of the oral fluorouracil antitumor agent S‐1 in patients with impaired renal function, Cancer Science, April 2019, Wiley,
DOI: 10.1111/cas.14025.
You can read the full text:

Read

Contributors

The following have contributed to this page